| The V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status has been identified as an important factor in the treatment of colorectal cancer. | sarcoma,colorectal, |
| Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene. | pancreatic, |
| A subset of endosalpingiotic lesions are clonal and harbour the same oncogenic driver mutations in KRAS shared with low-grade ovarianserous tumours. | ovarian, |
| Recurrent breast cancer and an adenocarcinoma of the lung occurring in one patient: c-myc oncogene amplification and K-ras codon 12 point mutation as tumour markers. | breast,lung, |
| Immunohistochemical detection of the ras oncogene product p21 in advanced ovarian cancer. Lack of correlation with clinical outcome. | ovarian, |
| Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues. | thyroid, |
| [Localization of oncoprotein P21ras in the human liver cancer]. | liver, |
| ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas. | gastric,colorectal, |
| Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions. | colorectal, |
| [Expression of Ha-ras oncogene product, p21 in gastric carcinoma]. | gastric, |
| A c-ras-Ki oncogene is activated, amplified and overexpressed in a human osteosarcoma cell line. | osteosarcoma, |
| Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. | colorectal, |
| Correlation of thyroid hormone dose-dependent regulation of K-ras protooncogene expression with oncogene activation by 3-methylcholanthrene: loss of thyroidal regulation in the transformed mouse cell. | thyroid, |
| ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma. | bladder, |
| The mitogenic/oncogenic p21 Ki-RAS protein stimulates adenylate cyclase activity early in the G1 phase of NRK rat kidney cells. | kidney, |
| Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. | colorectal,neoplasm, |
| Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum. | colorectal, |
| Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung. | lung, |
| A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. | gastric, |
| Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. | colorectal, |